Correction: Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss (Annals of the Rheumatic Diseases (2016) 75 (721-729) DOI: 10.1136/annrheumdis-2015-208093);Identification of a novel chemokine-dependent molecular mechanism underlying Rheumatoid arthritisassociated autoantibody-mediated bone loss

Annals of the Rheumatic Diseases

Volumn 75, Issue 4, 2016, Pages 721-729

  Krishnamurthy, Akilan ^a   Joshua, Vijay ^a   Hensvold, Aase Haj ^a   Jin, Tao ^b   Sun, Meng ^a   Vivar, Nancy ^a   Ytterberg, A Jimmy ^a,c   Engström, Marianne ^a   Fernandes Cerqueira, Cátia ^a   Amara, Khaled ^a   Magnusson, Malin ^b   Wigerblad, Gustaf ^c   Kato, Jungo ^c   Jiménez Andrade, Juan Miguel ^d   Tyson, Kerry ^e   Rapecki, Stephen ^e   Lundberg, Karin ^a   Catrina, Sergiu Bogdan ^c   Jakobsson, Per Johan ^a   Svensson, Camilla ^c   Malmström, Vivianne ^a   Klareskog, Lars ^a   Wähämaa, Heidi ^a   Catrina, Anca I ^a   more..

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c KAROLINSKA INSTITUTE   (Sweden)

^d UNIVERSIDAD AUTÓNOMA DE TAMAULIPAS   (Mexico)

^e UCB PHARMA   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AUTOANTIBODY; CYCLIC CITRULLINATED PEPTIDE ANTIBODY; IMMUNOGLOBULIN G; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; NEUTRALIZING ANTIBODY; OSTEOCLAST DIFFERENTIATION FACTOR; PROTEIN ARGININE DEIMINASE; REPARIXIN; TUMOR NECROSIS FACTOR ALPHA; 2-(4-ISOBUTYLPHENYL)PROPIONYLMETHANESULFONAMIDE; CHEMOKINE; CITRULLINE; HYDROLASE; INTERLEUKIN 8 RECEPTOR; PROTEIN-ARGININE DEIMINASE; SULFONAMIDE;

ANTIBODY SPECIFICITY; ARTICLE; B LYMPHOCYTE; BONE STRUCTURE; CELL ACTIVATION; CELL COUNT; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOLYSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RHEUMATOID ARTHRITIS; ANIMAL; ANTAGONISTS AND INHIBITORS; BAGG ALBINO MOUSE; BONE; CELL CULTURE TECHNIQUE; DIAGNOSTIC IMAGING; DRUG EFFECTS; FEMALE; IMMUNOLOGY; MALE; METABOLISM; MICRO-COMPUTED TOMOGRAPHY; MIDDLE AGED; MOUSE; SYNOVIAL FLUID;

ANIMALS; ARTHRITIS, RHEUMATOID; AUTOANTIBODIES; B-LYMPHOCYTES; BONE AND BONES; BONE RESORPTION; CELL CULTURE TECHNIQUES; CHEMOKINES; CITRULLINE; FEMALE; HUMANS; HYDROLASES; IMMUNOHISTOCHEMISTRY; INTERLEUKIN-8; MALE; MICE; MICE, INBRED BALB C; MIDDLE AGED; OSTEOCLASTS; RECEPTORS, INTERLEUKIN-8; SULFONAMIDES; SYNOVIAL FLUID; X-RAY MICROTOMOGRAPHY;

EID: 84961966554     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2015-208093corr1     Document Type: Erratum

References (34)

1. Klareskog L, Catrina AI, Paget S. Rheumatoid arthritis. Lancet 2009;373:659-72.
2. Rantapää-Dahlqvist S, de Jong BA, Berglin E, et al. Antibodies against cyclic citrullinated peptide and IgA rheumatoid factor predict the development of rheumatoid arthritis. Arthritis Rheum 2003;48:2741-9.
3. de Hair MJ, van de Sande MG, Ramwadhdoebe TH, et al. Features of the synovium of individuals at risk of developing rheumatoid arthritis: implications for understanding preclinical rheumatoid arthritis. Arthritis Rheumatol 2014;66:513-22.
4. van der Helm-van Mil AH, Verpoort KN, Breedveld FC, et al. Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 2005;7:R949-958.
5. Syversen SW, Goll GL, van der Heijde D, et al. Prediction of radiographic progression in rheumatoid arthritis and the role of antibodies against mutated citrullinated vimentin: results from a 10-year prospective study. Ann Rheum Dis 2010;69:345-51.
6. Takahara H, Okamoto H, Sugawara K. Calcium-dependent properties of peptidylarginine deiminase from rabbit skeletal-muscle. Agric Biol Chem 1986;50:2899-904.
7. Méchin MC, Enji M, Nachat R, et al. The peptidylarginine deiminases expressed in human epidermis differ in their substrate specificities and subcellular locations. Cell Mol Life Sci 2005;62:1984-95.
8. Vossenaar ER, Zendman AJW, van Venrooij WJ, et al. PAD, a growing family of citrullinating enzymes: genes, features and involvement in disease. Bioessays 2003;25:1106-18.
9. Senshu T, Kan S, Ogawa H, et al. Preferential deimination of keratin K1 and filaggrin during the terminal differentiation of human epidermis. Biochem Biophys Res Commun 1996;225:712-19.
10. Senshu T, Akiyama K, Nomura K. Identification of citrulline residues in the V subdomains of keratin K1 derived from the cornified layer of newborn mouse epidermis. Exp Dermatol 1999;8:392-401.
11. Harding CR, Scott IR. Histidine-rich proteins (filaggrins): structural and functional heterogeneity during epidermal differentiation. J Mol Biol 1983;170:651-73.
12. Pearton DJ, Dale BA, Presland RB. Functional analysis of the profilaggrin N-terminal peptide: identification of domains that regulate nuclear and cytoplasmic distribution. J Invest Dermatol 2002;119:661-9.
13. Scott IR, Harding CR, Barrett JG. Histidine-rich protein of the keratohyalin granules. Source of the free amino acids, urocanic acid and pyrrolidone carboxylic acid in the stratum corneum. Biochim Biophys Acta 1982;719:110-17.
14. Moscarello MA, Wood DD, Ackerley C, et al. Myelin in multiple sclerosis is developmentally immature. J Clin Invest 1994;94:146-54.
15. Beniac DR, Wood DD, Palaniyar N, et al. Cryoelectron microscopy of protein-lipid complexes of human myelin basic protein charge isomers differing in degree of citrullination. J Struct Biol 2000;129:80-95.
16. Makrygiannakis D, af Klint E, Lundberg IE, et al. Citrullination is an inflammation-dependent process. Ann Rheum Dis 2006;65:1219-22.
17. Vossenaar ER, Smeets TJM, Kraan MC, et al. The presence of citrullinated proteins is not specific for rheumatoid synovial tissue. Arthritis Rheum 2004;50:3485-94.
18. Kraan MC, Patel DD, Haringman JJ, et al. The development of clinical signs of rheumatoid synovial inflammation is associated with increased synthesis of the chemokine CXCL8 (interleukin-8). Arthritis Res 2001;3:65-71.
19. Kleyer A, Schett G. Arthritis and bone loss: a hen and egg story. Curr Opin Rheumatol 2014;26:80-4.
20. Kopesky P, Tiedemann K, Alkekhia D, et al. Autocrine signaling is a key regulatory element during osteoclastogenesis. Biol Open 2014;3:767-76.
21. Molenaar ET, Voskuyl AE, Dinant HJ, et al. Progression of radiologic damage in patients with rheumatoid arthritis in clinical remission. Arthritis Rheum 2004;50:36-42.
22. Kleyer A, Finzel S, Rech J, et al. Bone loss before the clinical onset of rheumatoid arthritis in subjects with anticitrullinated protein antibodies. Ann Rheum Dis 2014;73:854-60.
23. Ossipova E, Cerqueira CF, Reed E, et al. Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint. Arthritis Res Ther 2014;16:R167.
24. Amara K, Steen J, Murray F, et al. Monoclonal IgG antibodies generated from joint-derived B cells of RA patients have a strong bias toward citrullinated autoantigen recognition. J Exp Med 2013;210:445-55.
25. Zendman AJ, Raijmakers R, Nijenhuis S, et al. ABAP: antibody-based assay for peptidylarginine deiminase activity. Anal Biochem 2007;369:232-40.
26. Ali A, Welin A, Schwarze JC, et al. CTLA4-Ig but not anti-TNF therapy promotes staphylococcal septic arthritis in mice. J Infect Dis 2015;212:1308-16.
27. Ali A, Zhu X, Kwiecinski J, et al. Antibiotic-killed Staphylococcus aureus induces destructive arthritis in mice. Arthritis Rheumatol 2015;67:107-16.
28. Hansson M, Mathsson L, Schlederer T, et al. Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides. Arthritis Res Ther 2012;14:R201.
29. Harre U, Lang SC, Pfeifle R, et al. Glycosylation of immunoglobulin G determines osteoclast differentiation and bone loss. Nat Commun 2015;6:6651.
30. Souza PP, Lerner UH. The role of cytokines in inflammatory bone loss. Immunol Invest 2013;42:555-622.
31. Rothe L, Collin-Osdoby P, Chen Y, et al. Human osteoclasts and osteoclast-like cells synthesize and release high basal and inflammatory stimulated levels of the potent chemokine interleukin-8. Endocrinology 1998;139:4353-63.
32. Harre U, Georgess D, Bang H, et al. Induction of osteoclastogenesis and bone loss by human autoantibodies against citrullinated vimentin. J Clin Invest 2012;122:1791-802.
33. Marinova-Mutafchieva L, Williams RO, Funa K, et al. Inflammation is preceded by tumor necrosis factor-dependent infiltration of mesenchymal cells in experimental arthritis. Arthritis Rheum 2002;46:507-13.
34. Khandpur R, Carmona-Rivera C, Vivekanandan-Giri A, et al. NETs are a source of citrullinated autoantigens and stimulate inflammatory responses in rheumatoid arthritis. Sci Transl Med 2013;5:178ra140.